Haloperidol and Nephrogenic systemic fibrosis - a phase IV clinical study of FDA data

Summary:

Nephrogenic systemic fibrosis is reported as a side effect among people who take Haloperidol (haloperidol), especially for people who are male, 60+ old, also take Omniscan, and have Nuclear magnetic resonance imaging brain.

The phase IV clinical study analyzes which people have Nephrogenic systemic fibrosis when taking Haloperidol. It is created by eHealthMe based on reports of 16,432 people who have side effects when taking Haloperidol from the FDA, and is updated regularly.

What is Haloperidol?

Haloperidol has active ingredients of haloperidol. It is often used in schizophrenia. eHealthMe is studying from 16,637 Haloperidol users. Check the latest studies of Haloperidol.

What is Nephrogenic systemic fibrosis?

Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease) is found to be associated with 503 drugs and 673 conditions by eHealthMe. Check the latest studies of Nephrogenic systemic fibrosis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

16,432 people reported to have side effects when taking Haloperidol.
Among them, 22 people (0.13%) have Nephrogenic systemic fibrosis.

Could Haloperidol cause Nephrogenic systemic fibrosis?

Among these 22 people:

What is the gender of people who have Nephrogenic systemic fibrosis when taking Haloperidol? *

female: 50 %
male: 50 %

What is the age of people who have Nephrogenic systemic fibrosis when taking Haloperidol? *

What are other drugs people take besides Haloperidol? *

What are other side effects people have besides Nephrogenic systemic fibrosis? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 31.82%
Joint Pain: 7 people, 31.82%
Aortic Arteriosclerosis (hardening of the aortic arteries): 6 people, 27.27%
Aortic Stenosis (obstruction to the outflow of blood from the left ventricle into the aorta): 6 people, 27.27%
Aortic Valve Incompetence: 6 people, 27.27%
Mitral Valve Incompetence (inefficient heart valve): 6 people, 27.27%
Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 5 people, 22.73%
Abdominal Pain: 5 people, 22.73%
Mitral Valve Calcification (calcium deposit in mitral valve): 5 people, 22.73%
Restless Leg Syndrome (a powerful urge to move your legs): 5 people, 22.73%

What are the existing conditions these people have? *

Nuclear Magnetic Resonance Imaging Brain: 5 people, 22.73%
Fever: 4 people, 18.18%
Lymphoma (cancer that begins in immune system cells): 1 person, 4.55%
Lymph Node Cancer Metastatic (cancer of lymph node spreads to other part): 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Haloperidol and have Nephrogenic systemic fibrosis?

- Check whether Nephrogenic systemic fibrosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Haloperidol:

Haloperidol (16,637 reports)

Browse all side effects of Haloperidol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nephrogenic systemic fibrosis:

Nephrogenic systemic fibrosis (503 drugs)

Browse all the conditions that are associated with Nephrogenic systemic fibrosis:

Nephrogenic systemic fibrosis (673 conditions)

Related publications that referenced our studies

Obayi, O., & Tagbo, N. , "Bilateral Pedal Oedema Associated with Intramuscular Haloperidol–A Rare Observation", International Neuropsychiatric Disease Journal, 2018 Jan .
Obayi, O., & Tagbo, N. , "Bilateral Pedal Oedema Associated with Intramuscular Haloperidol–A Rare Observation", International Neuropsychiatric Disease Journal, 2018 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on haloperidol (the active ingredients of Haloperidol) and Haloperidol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.